Medical/Pharmaceuticals
World Stroke Organization Tackle Gaps in Access to Quality Stroke Care
GENEVA, Switzerland, Oct. 28, 2022 /PRNewswire/ -- On World Stroke Day (29th
Oct), the World Stroke Organization has announced the launch of a new program
that aims to drive access to quality acute stroke care and save lives around
the world.
2022-10-29 06:01
9120
Hinova Disclosed the Preclinical Results of HP518 (Oral AR PROTAC) at the 5th Annual TPD Summit
BOSTON, Oct. 29, 2022 /PRNewswire/ -- Hinova Pharmaceuticals Inc. (STAR: 688302), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for cancers and metabolic diseases through targeted protein degradation technologies, today presented their preclinical results of ...
2022-10-29 05:30
8916
GORE COMPLETES FIRST IN-HUMAN IMPLANTS OF THE GORE® VIAFORT VASCULAR STENT
CAUTION: Investigational device. Limited by United States law to investigational use. W. L. Gore & Associates initiates its GORE® VIAFORT Device Pivotal Clinical Study for the treatment of inferior vena cava occlusive disease. FLAGSTAFF, Ariz., Oct. 29, 2022 /PRNewswire/ -- W. L. Gore & Associat...
2022-10-29 02:10
8790
Future of Healthcare Week Asia: Building sustainable systems for all
* A hybrid event unifying the public, private and civil sectors from health and technology to foster better healthcare for all and ensure continuity of care. * Speakers include Budi Gunadi Sadikin, Indonesia's Minister of Health; Kai-Fu Lee, Sinovation Ventures's chairman and chief executive;...
2022-10-28 20:32
2788
Stamford American celebrates Global Be Well Day, highlighting the importance of well-being
Stamford American students take time during Global Be Well Day to do stretching exercises on the sports field and dance to music. SINGAPORE, Oct. 28, 2022 /PRNewswire/ -- Well-being has been one of the most important issues facingSingapore recently, and there are signs the Lion City has begun to...
2022-10-28 14:56
2473
Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib
Marketing authorisation in the European Economic Area anticipated in H1 2023 LEIDEN, Netherlands, Oct. 28, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM / Nasdaq: PHAR) announces today that its Marketing Authorisation Application (MAA) for leni...
2022-10-28 13:00
3780
2022 Digitisation in Traditional Medicine World Summit successfully held in Macau
Joint discussion on digitisation with credit initiative between China and ASEAN countries MACAU, Oct. 28, 2022 /PRNewswire/ -- Here is the report from Macau business By Tony Lai: A conference about digitisation of the industry of Traditional Complementary Medicine (TCM) was held inMacau on Frida...
2022-10-28 11:36
940
Acceptance Of The Application For Clinical Trial Of Recbio Novel Adjuvanted Recombinant Quadrivalent HPV Vaccine
TAIZHOU, China, Oct. 28, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that, the Group has recently received a notice of acceptance from the National Medical Products Administration to accept the appli...
2022-10-28 11:10
2969
Sebela Pharmaceuticals® Acquires Exclusive Licensing Rights to Develop and Commercialize Tegoprazan in the U.S. and Canada
Phase 3 Trials Initiated with Tegoprazan for the Treatment of Erosive Esophagitis and Non-erosive Reflux Disease BRAINTREE, Mass., Oct. 28, 2022 /PRNewswire/ -- Sebela Pharmaceuticals® has entered an exclusive partnership with HK inno.N Corporation to license tegoprazan inthe United States and C...
2022-10-28 09:00
2125
Sciwind Biosciences Announces Positive Interim Results from Ongoing Phase 2b Clinical Trial of XW003 (Ecnoglutide) in Patients with Obesity
- Mean body weight loss of 11.1% in participants receiving once-weekly injections of 2.4 mg XW003 for 18 weeks - 88.5% and 57.7% of participants receiving 2.4 mg XW003 for 18 weeks achieved weight loss of≥5% and ≥10%, respectively - XW003 was safe and well tolerated, with an adverse event p...
2022-10-28 08:00
2226
hemotune Applauded by Frost & Sullivan for Enabling Selective and Efficient Extraction of Large Compounds from Blood With Its Blood Purification Platform
HemoSystem improves patient outcomes while shortening the length of stay in intensive care units, reducing the sepsis burden for patients, hospitals, and healthcare systems. SAN ANTONIO, Oct. 27, 2022 /PRNewswire/ -- Recently, Frost & Sullivan assessed the blood purification technology industry a...
2022-10-27 23:00
2256
Life sciences industry's highest achievers celebrated at prestigious Awards ceremony
AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards * Industry Leadership Award: Professors Steve Wilton AO and Sue Fletcher AO * Company of the Year: Telix Pharmaceuticals * Emerging Company of the Year: Fusetec AusBiotech Life Sciences Legacy Award: Dr Andrew Forrest AO a...
2022-10-27 22:39
2964
Mentice Launches New Website
GOTHENBURG, Sweden, Oct. 27, 2022 /PRNewswire/ -- Mentice, a world leader in virtual and physical simulation solutions for Image-guided Interventional Therapies, is pleased to announce the launch of its new websitewww.mentice.com . Mentice is proud to present the platform's innovative design, s...
2022-10-27 22:02
2240
Medtecs to showcase its world-leading PPE solutions in Germany and France
TAIPEI, Oct. 27, 2022 /PRNewswire/ -- As countries reopen their borders for international travel with global vaccination coverage on the rise, the world is slowly returning to pre-pandemic activity levels since the COVID-19 outbreak nearly 3 years ago. Needless to say, personal protective equi...
2022-10-27 18:14
881
Cambrex to Invest $16.5 Million in New R&D Facility in Minneapolis, Minnesota and Expansion in Charles City, Iowa
EAST RUTHERFORD, N.J., Oct. 27, 2022 /PRNewswire/ -- Cambrex today announced it is investing in a new, 21,000-square-foot research and development facility in Minneapolis, Minnesota, expanding its capacity for small molecule development and manufacturing. Strategically located near the Minneapolis...
2022-10-27 18:00
1982
Gerresheimer and Merck Transform Primary Packaging into Digital Twins
DÜSSELDORF, Germany, Oct. 27, 2022 /PRNewswire/ -- Gerresheimer AG, a leading provider of healthcare solutions and drug delivery systems for pharma, biotech and cosmetics and Merck, Darmstadt, a leading science and technology company, jointly developed a digital twin solution to further ensure tr...
2022-10-27 16:50
2002
Telix Recognised as Company of the Year at AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards 2022
MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is today pleased to announce that it has been awarded Australian Company of the Year in the 2022 AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards, held today at t...
2022-10-27 10:23
2781
DR. FAIKA KHAN CEO OF CITY DOCTOR PVT. LTD. AND MR ALI J HASHMAT CEO OF CURE PARTNERS PVT. LTD. ANNOUNCEMENT OF FULL ACQUISITION OF "THE MEDICAL LABORATORY PVT. LTD." DBA ZEENAT LABORATORIES
NEW YORK, Oct. 27, 2022 /PRNewswire/ -- Dr Faika Khan CEO of CITY DOCTOR PVT. LTD. andMr. Ali J Hashmat of CURE PARTNERS PVT. LTD. announced 100% acquisition of"The Medical laboratory Pvt. Ltd." Doing Businesses as (DBA) "ZEENAT LAB", one of the most renowned lab with a history of over 50 plus ye...
2022-10-27 10:19
1982
SUCCESSFUL PASSING OF EU QP AUDIT ON TOT BIOPHARM'S COMMERCIAL PRODUCTION BASE FOR MONOCLONAL ANTIBODY DRUG SUBSTANCES AND ANTIBODY DRUG CONJUGATES
SUZHOU,China, Oct. 27, 2022 /PRNewswire/ -- TOT BIOPHARM International Company Limited (TOT BIOPHARM, Stock code: 1875.HK) has recently received a GMP compliance inspection report approved by aQualified Person ("QP") in the European Union ("EU") in respect of the manufacturing facilities and asso...
2022-10-27 08:00
2177
JW Therapeutics and 2seventy bio Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies
* Initial focus on accelerating development of 2seventy's MAGE-A4 program in solid tumors inChina SHANGHAI, China and CAMBRIDGE, Mass., Oct. 27, 2022 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and comme...
2022-10-27 07:53
3339
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 321 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 303 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39
Trip.com Group and Rezdy Join Forces to Offer New Travel Experiences Around the World
[Picked up by 229 media titles]
2024-05-14 18:07Most Read
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
2024-05-15 12:00
8263
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
2024-05-16 15:00
6458
Traveloka strengthens sustainability pledge as world's first Platinum Sponsor of GSTC
2024-05-13 16:42
6406
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
2024-05-16 09:39
6176
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
2024-05-15 09:00
6139
